NCT05329701View on ClinicalTrials.gov

Individualized Duration of Antibiotic Treatment in Early Onset Infection in Newborns.

PHASE4RecruitingINTERVENTIONAL

Enrollment

488

Participants

Timeline

Start Date

April 22, 2022

Primary Completion Date

April 18, 2025

Study Completion Date

April 18, 2028

Conditions

Early-Onset Neonatal SepsisAntibiotic Side Effect

Interventions

OTHER

Individualized treatment duration strategy

As listed under arm description.

Trial Locations (1)

2100

RECRUITING

Ulrikka Nygaard, Copenhagen

Sponsors

Collaborators (1)

Innovation Fund Denmark

All Listed Sponsors

collaborator

Innovation Fund Denmark

INDIV

collaborator

University of Copenhagen

OTHER

lead

Ulrikka Nygaard

OTHER

NCT05329701 - Individualized Duration of Antibiotic Treatment in Early Onset Infection in Newborns. | Biotech Hunter | Biotech Hunter